bromodeoxyuridine has been researched along with dihydropyridines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futamura, Y; Hamada, Y | 1 |
| Chen, IJ; Chiu, CC; Liang, JC; Lin, YT; Liou, SF; Yeh, JL | 1 |
2 other study(ies) available for bromodeoxyuridine and dihydropyridines
| Article | Year |
|---|---|
Induction of Leydig cell tumors by lacidipine via up-regulation of the LHRH receptor on Leydig cells in rats.
Topics: Administration, Oral; Animals; Bromodeoxyuridine; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Leydig Cell Tumor; Leydig Cells; Luteinizing Hormone; Macaca mulatta; Male; Mice; Nicardipine; Protein Kinases; Proto-Oncogenes; Rats; Rats, Sprague-Dawley; Receptors, LHRH; Species Specificity; Testosterone; Up-Regulation | 1998 |
Inhibition of mitogen-mediated proliferation of rat vascular smooth muscle cells by labedipinedilol-A through PKC and ERK 1/2 pathway.
Topics: Animals; Anisoles; Aorta, Thoracic; Bromodeoxyuridine; Calcium; Cell Culture Techniques; Cell Movement; Cell Proliferation; China; Dihydropyridines; DNA; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Focal Adhesion Kinase 2; Humans; Interphase; Isoenzymes; Male; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Muscle, Smooth, Vascular; Phosphorylation; Platelet-Derived Growth Factor; Proliferating Cell Nuclear Antigen; Proline; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Umbilical Veins | 2004 |